1. Home
  2. ZVIA vs DBVT Comparison

ZVIA vs DBVT Comparison

Compare ZVIA & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVIA
  • DBVT
  • Stock Information
  • Founded
  • ZVIA 2007
  • DBVT 2002
  • Country
  • ZVIA United States
  • DBVT France
  • Employees
  • ZVIA N/A
  • DBVT N/A
  • Industry
  • ZVIA Beverages (Production/Distribution)
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ZVIA Consumer Staples
  • DBVT Health Care
  • Exchange
  • ZVIA Nasdaq
  • DBVT Nasdaq
  • Market Cap
  • ZVIA 204.8M
  • DBVT 237.4M
  • IPO Year
  • ZVIA 2021
  • DBVT N/A
  • Fundamental
  • Price
  • ZVIA $3.11
  • DBVT $10.50
  • Analyst Decision
  • ZVIA Hold
  • DBVT Buy
  • Analyst Count
  • ZVIA 2
  • DBVT 4
  • Target Price
  • ZVIA $3.38
  • DBVT $14.81
  • AVG Volume (30 Days)
  • ZVIA 1.0M
  • DBVT 28.2K
  • Earning Date
  • ZVIA 08-06-2025
  • DBVT 07-29-2025
  • Dividend Yield
  • ZVIA N/A
  • DBVT N/A
  • EPS Growth
  • ZVIA N/A
  • DBVT N/A
  • EPS
  • ZVIA N/A
  • DBVT N/A
  • Revenue
  • ZVIA $154,273,000.00
  • DBVT $3,497,000.00
  • Revenue This Year
  • ZVIA $5.66
  • DBVT $1,700.53
  • Revenue Next Year
  • ZVIA $6.76
  • DBVT $535.67
  • P/E Ratio
  • ZVIA N/A
  • DBVT N/A
  • Revenue Growth
  • ZVIA N/A
  • DBVT N/A
  • 52 Week Low
  • ZVIA $0.62
  • DBVT $2.21
  • 52 Week High
  • ZVIA $4.99
  • DBVT $12.78
  • Technical
  • Relative Strength Index (RSI)
  • ZVIA 52.91
  • DBVT 61.36
  • Support Level
  • ZVIA $3.00
  • DBVT $9.13
  • Resistance Level
  • ZVIA $3.66
  • DBVT $10.80
  • Average True Range (ATR)
  • ZVIA 0.28
  • DBVT 0.72
  • MACD
  • ZVIA -0.00
  • DBVT 0.14
  • Stochastic Oscillator
  • ZVIA 52.56
  • DBVT 86.74

About ZVIA Zevia PBC

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: